AMLX - Amylyx Pharmaceuticals Inc Earnings

Peers: PTCT ACAD SUPN FOLD RYTM

| Held by: VTI IWM VXF IBB IWO VTWO XPH SCHA DFMC IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.51	Insider Own	16.51%	Shs Outstand	111.03M	Perf Week	-9.81%
Market Cap	1.48B	Forward P/E	-	EPS next Y	-1.27	Insider Trans	-2.21%	Shs Float	92.83M	Perf Month	-25.07%
Enterprise Value	1.20B	PEG	-	EPS next Q	-0.35	Inst Own	96.09%	Short Float	15.94%	Perf Quarter	-5.91%
Income	-150.11M	P/S	-	EPS this Y	7.86%	Inst Trans	0.65%	Short Ratio	13.66	Perf Half Y	7.75%
Sales	0.00M	P/B	5.40	EPS next Y	9.85%	ROA	-58.49%	Short Interest	14.80M	Perf YTD	9.98%
Book/sh	2.46	P/C	5.28	EPS next 5Y	27.97%	ROE	-63.26%	52W High	18.60 -28.59%	Perf Year	193.92%
Cash/sh	2.52	P/FCF	-	EPS past 3/5Y	19.94% -15.37%	ROIC	-54.07%	52W Low	4.26 211.49%	Perf 3Y	-52.79%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.69% 5.16%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	51.42%	Oper. Margin	-	ATR (14)	0.83	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.85	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	30.09	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	17.85	EPS Q/Q	10.88%	SMA20	-16.39%	Beta	-0.15	Target Price	23.40
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	-13.49%	Rel Volume	0.91	Prev Close	13.88
Employees	136	LT Debt/Eq	0.02	Earnings	May 07 BMO	SMA200	-1.02%	Avg Volume	1.08M	Price	13.28
IPO	Jan 07, 2022	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.50% -	Trades		Volume	989,931	Change	-4.29%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)